Los Altos, CA, United States of America

Mark D Bednarski

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Epicentrx, Inc., Northrop Grumman Systems Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark D Bednarski. Retrieved from https://idiyas.com/inventor/mark-d-bednarski-9cmmyzca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark D Bednarski: Innovator in Cyclic Nitro Compounds

Introduction

Mark D Bednarski is a notable inventor based in Los Altos, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cyclic nitro compounds. His research focuses on developing treatments for various diseases characterized by abnormal cell proliferation.

Latest Patents

Mark D Bednarski holds a patent for "Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof." This invention provides cyclic nitro compounds and pharmaceutical compositions that can be utilized to treat or prevent diseases such as cancer, inflammation, cardiovascular disease, and autoimmune diseases. His work is crucial in advancing therapeutic options for these serious health conditions.

Career Highlights

Throughout his career, Mark has worked with prominent organizations, including Northrop Grumman Systems Corporation and Epicentrx, Inc. His experience in these companies has allowed him to develop his expertise in pharmaceutical innovations and contribute to significant advancements in medical science.

Collaborations

Mark has collaborated with various professionals in his field, including his coworker Susan Knox. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new pharmaceutical solutions.

Conclusion

Mark D Bednarski's contributions to the field of cyclic nitro compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new treatments that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…